MeSH tree: N01.224.935.464.750
New research, led by experts at the University of Nottingham, has found that smoking prevalence among 12- to 30-year-olds in England could drop below 5% decades earlier than expected, if the government progressively raises ...
Feb 11, 2026
0
7
A Medicare-covered program that offers support and medical advice for caregivers of patients with dementia may bring more benefit than a costly Alzheimer's medication, research finds. UC San Francisco researchers have compared ...
Feb 5, 2026
0
8
Semaglutide, the active ingredient in the weight-loss medications Ozempic and Wegovy, offers substantial cardiovascular benefits for selected patients without diabetes who have established heart disease, but further price ...
Feb 4, 2026
0
16
Decades of advances in medical technology and public health are causing global populations to age. While achieving longer lives is certainly a net positive, this demographic shift is placing an ever-growing strain on national ...
Jan 8, 2026
0
25
Thanks to vaccinations against SARS-CoV-2 in the period 2020–2024, 2.533 million deaths were prevented at the global level; one death was avoided for every 5,400 doses of vaccine administered.
Jul 25, 2025
0
81
Homelessness and opioid use disorder are two widespread public health problems in the United States. Providing housing and supportive services, without requiring drug treatment, is a surprisingly cost-effective approach to ...
Jun 27, 2025
0
36
A new pilot program is the first to use a shared interest in pets to help build connections between young and older adults to reduce loneliness and social isolation.
Apr 28, 2025
0
17
Polypill treatment for cardiovascular disease prevention is of high value in a low-income, underserved population, according to research published in JAMA Cardiology.
Jan 13, 2025
0
16
Krishna Reddy, MD, MS, a physician-investigator at the Medical Practice Evaluation Center and the Tobacco Research and Treatment Center at Massachusetts General Hospital and an Associate Professor of Medicine at Harvard Medical ...
Sep 11, 2024
0
60
Vaccination against respiratory syncytial virus for adults over 60 is likely to be cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.
Sep 5, 2024
0
56
